Molina Healthcare, Inc. (MOH)

Molina Healthcare's stock has experienced significant fluctuations in the past six months, declining by 38.83% from May 5, 2025, to May 4, 2026. Over the last 12 months, the stock's price decreased by 37.65%, although it saw a year-to-date return of 13.62% and an increase of 41.88% in the past month as of early May 2026. Key events impacting the stock include the release of the Fourth Quarter and Year-End 2025 financial results on February 5, 2026, health insurers' stocks soaring after securing a better Medicare Advantage rate for 2027 on April 7, 2026, the First Quarter 2026 Earnings Conference Call on April 23, 2026, and the Investor Day on May 8, 2026, where Molina Healthcare set an ambitious target of $25 of adjusted EPS for 2029.

Demand for Molina Healthcare's products and services exhibits some seasonality, influenced by annual competition for members in the Medicare and Marketplace segments, Medicaid redetermination processes, and the fixed benefit period for over-the-counter (OTC) benefit allowances.

Molina Healthcare, Inc. operates in the Healthcare sector, providing managed healthcare services primarily through government programs like Medicaid and Medicare, and state insurance marketplaces. Its major products include Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans. Molina also offers virtual care services and various over-the-counter products. As of December 31, 2025, Molina Healthcare served approximately 5.5 million members.

Molina Healthcare's geographic footprint is concentrated within the United States, where it provides health plans in approximately 21 states, including California, Florida, Michigan, New Mexico, New York, Ohio, Texas, Utah, Washington, and Wisconsin, and Puerto Rico. Its largest markets by membership and revenue as of 2025 are California, Texas, Florida, Ohio, and Washington.

In the past year, Molina Healthcare's brand reputation has faced scrutiny due to legal investigations initiated by Kahn Swick & Foti, LLC into the officers and directors of Molina Healthcare, Inc. in March and April 2026, suggesting potential concerns regarding corporate governance or conduct.

Molina Healthcare, Inc. is largely institutionally-dominated, with institutional investors holding a significant portion of the company's stock, often cited around 78.45% to over 98%. Major institutional shareholders include Vanguard Group Inc, BlackRock, Inc., Capital World Investors, Fmr Llc, Harris Associates L P, State Street Corp, Invesco Ltd., Victory Capital Management Inc, Geode Capital Management, Llc, and T. Rowe Price Investment Management, Inc. The Molina family, specifically John C. Molina, holds a substantial individual stake, representing about 9.50% of the company's outstanding stock.